Cargando…

Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer()

Colorectal cancer (CRC) is a major public health problem. Early CRC detection, pretherapeutic responsiveness prediction, and postoperative micrometastasis monitoring are the hallmarks for successful CRC treatment. Here, the methodologies used for detecting circulating tumor cells (CTCs) from CRC are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ming-Yii, Tsai, Hsiang-Lin, Huang, Joh-Jong, Wang, Jaw-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006809/ https://www.ncbi.nlm.nih.gov/pubmed/27567958 http://dx.doi.org/10.1016/j.tranon.2016.06.006

Ejemplares similares

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

The Functional Significance of MicroRNA-29c in Patients with Colorectal Cancer: A Potential Circulating Biomarker for Predicting Early Relapse
por: Yang, I-Ping, et al.
Publicado: (2013)

A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer
por: Chang, Yu-Tang, et al.
Publicado: (2016)

Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Biomarkers in colorectal cancer: Current clinical utility and future perspectives
por: Vacante, Marco, et al.
Publicado: (2018)

Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
por: Huang, Ming-Yii, et al.
Publicado: (2018)

Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives
por: Grizzi, Giulia, et al.
Publicado: (2023)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Robotic colorectal surgery for laparoscopic surgeons with limited experience: preliminary experiences for 40 consecutive cases at a single medical center
por: Huang, Ching-Wen, et al.
Publicado: (2015)

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013)

Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review
por: Huang, Chun-Ming, et al.
Publicado: (2022)

ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation
por: Huang, Ming-Yii, et al.
Publicado: (2020)

Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer
por: Ko, Sung Woo, et al.
Publicado: (2023)

Clinical Implications of Lymph Node Metastasis in Colorectal Cancer: Current Status and Future Perspectives
por: Kim, Hye Jin, et al.
Publicado: (2019)

Clinical Implication of UGT1A1 Promoter Polymorphism for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Combined with FOLFIRI in the First-line Setting()()
por: Lu, Chien-Yu, et al.
Publicado: (2015)

Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Huang, Chun-Ming, et al.
Publicado: (2021)

Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer
por: Huang, Ching-Wen, et al.
Publicado: (2015)

Detection and clinical significance of circulating tumor cells in colorectal cancer
por: Jiang, Miao, et al.
Publicado: (2021)

The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2012)

Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer
por: Chen, Kehe, et al.
Publicado: (2022)

Factors affecting number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I-III colorectal cancer patients: a retrospective single institution cohort study of 1167 consecutive patients
por: Tsai, Hsiang-Lin, et al.
Publicado: (2016)

Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review
por: Bach, Sander, et al.
Publicado: (2019)

Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer
por: Huang, Chun-Ming, et al.
Publicado: (2017)

A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma
por: Huang, Chun-Ming, et al.
Publicado: (2017)

Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)

Excision repair cross-complementing group 2 upregulation is a potential predictive biomarker for oral squamous cell carcinoma recurrence
por: Wang, Yen-Yun, et al.
Publicado: (2021)

Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2017)

Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
por: Komarnicki, Paweł, et al.
Publicado: (2022)

Biology, detection, and clinical implications of circulating tumor cells
por: Joosse, Simon A, et al.
Publicado: (2015)

MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review
por: Yang, I-Ping, et al.
Publicado: (2023)

Genomic and Metabolomic Landscape of Right-Sided and Left-Sided Colorectal Cancer: Potential Preventive Biomarkers
por: Su, Ming-Wei, et al.
Publicado: (2022)

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
por: de Abreu, Ana Regina, et al.
Publicado: (2023)

Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer
por: Pan, Cheng, et al.
Publicado: (2017)

An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2016)

Women’s involvement in clinical trials: historical perspective and future implications
por: Liu, Katherine A., et al.
Publicado: (2016)

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
por: Qiu, Jie, et al.
Publicado: (2023)

Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
por: Puccini, Alberto, et al.
Publicado: (2022)

Circulating tumor cells in neuroblastoma: Current status and future perspectives
por: Yang, Ran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ertbdhfd8hjb6uoad253k9m7or